1-1 of 1
Authors: Megan Folkerts
Journal Article
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor‐Positive Metastatic Triple‐Negative Breast Cancer
The Oncologist, Volume 26, Issue 2, February 2021, Pages 99–e217, https://doi.org/10.1002/onco.13583
Published: 24 November 2020
